We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.76B
AUM Growth
+$143M
Cap. Flow
-$59.1M
Cap. Flow %
-2.14%
Top 10 Hldgs %
30.84%
Holding
95
New
14
Increased
24
Reduced
13
Closed
10

Top Buys

Rank Stock Value
1
PNT
POINT Biopharma Global Inc. Common Stock
PNT
+$38.3M
2
HCA icon
HCA Healthcare
HCA
+$34.9M
3
BIIB icon
Biogen
BIIB
+$29.6M
4
PEN icon
Penumbra
PEN
+$28.4M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$24.6M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$80.8M
2
PFE icon
Pfizer
PFE
+$70.4M
3
MRK icon
Merck
MRK
+$54.6M
4
BDX icon
Becton Dickinson
BDX
+$32.2M
5
UHS icon
Universal Health Services
UHS
+$32M

Sector Composition

Rank Sector Weight
1 Healthcare 88.58%
2 Financials 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OSH
51
DELISTED
Oak Street Health, Inc.
OSH
$17.7M 0.64%
722,844
+104,083
+17% +$2.75M
GBIO
52
DELISTED
Generation Bio
GBIO
$16M 0.58%
301,371
+24,040
+9% +$1.5M
EDIT icon
53
Editas Medicine
EDIT
$422M
$15.7M 0.57%
1,279,054
+649,370
+103% +$10.1M
BMRN icon
54
CALL
BioMarin Pharmaceuticals
BMRN
$11.6B
$15.3M 0.55%
+180,000
New +$16M
MYGN icon
55
Myriad Genetics
MYGN
$301M
$14.2M 0.51%
742,138
-435,112
-37% -$9.98M
HOWL icon
56
Werewolf Therapeutics
HOWL
$19.5M
$12.7M 0.46%
2,815,654
+1,084,931
+63% +$5.89M
ELV icon
57
Elevance Health
ELV
$84.8B
$11.7M 0.42%
25,800
-16,934
-40% -$8.1M
OM icon
58
Outset Medical
OM
$94.9M
$11.6M 0.42%
+48,628
New +$13M
ITOS
59
DELISTED
iTeos Therapeutics
ITOS
$10.2M 0.37%
537,954
– –
PMVP icon
60
PMV Pharmaceuticals
PMVP
$62.4M
$10.2M 0.37%
855,164
-359,000
-30% -$5.19M
ADAP
61
DELISTED
Adaptimmune Therapeutics
ADAP
$10M 0.36%
9,320,584
+210,804
+2% +$387K
JNCE
62
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$9.58M 0.35%
4,094,488
+144,820
+4% +$513K
BPMC
63
DELISTED
Blueprint Medicines
BPMC
$8.59M 0.31%
+130,366
New +$8.37M
APLS
64
DELISTED
Apellis Pharmaceuticals
APLS
$8.32M 0.3%
+121,880
New +$7.21M
PRAX icon
65
Praxis Precision Medicines
PRAX
$8.9B
$7.85M 0.28%
230,568
+10,745
+5% +$535K
CANO
66
DELISTED
Cano Health, Inc.
CANO
$6.74M 0.24%
+7,769
New +$4.87M
IOBT
67
DELISTED
IO Biotech
IOBT
$5.85M 0.21%
2,159,155
– –
PRTA icon
68
CALL
Prothena Corp
PRTA
$444M
$4.88M 0.18%
+80,500
New +$2.54M
BLSA
69
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$4.65M 0.17%
464,103
– –
JYAC
70
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$4.63M 0.17%
464,103
– –
ISEE
71
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$4.6M 0.17%
256,284
-649,732
-72% -$8.53M
CMPS
72
Compass Pathways
CMPS
$1.83B
$4.27M 0.15%
397,711
+4,947
+1% +$74.1K
SANA icon
73
Sana Biotechnology
SANA
$977M
$4.15M 0.15%
691,464
-261,269
-27% -$1.89M
LUNG icon
74
Pulmonx
LUNG
$83.6M
$3.33M 0.12%
+199,703
New +$3.68M
EPIX
75
DELISTED
ESSA Pharma
EPIX
$2.69M 0.1%
1,478,252
+516,536
+54% +$1.36M
1 2
3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return

PFM Health Sciences's Q3 2022 Portfolio in Review

As of Q3 2022, PFM Health Sciences held 95 positions worth $2.76B, up 5.4% from $2.62B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

PFM Health Sciences's Q3 2022 filing shows 14 new, 24 increased, 13 reduced and 10 closed positions. Its largest new stake was POINT Biopharma Global Inc. Common Stock: 4,515,216 shares worth $34.9M. The largest sale was Johnson & Johnson, an estimated $80.8M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, down from 94% a quarter earlier, followed by Financials.

  • PFM Health Sciences's largest Q3 2022 buy was POINT Biopharma Global Inc. Common Stock: 4,515,216 shares worth $34.9M.
  • PFM Health Sciences added most to Penumbra in Q3 2022, an estimated $28.4M increase.
  • PFM Health Sciences's biggest Q3 2022 reduction was Johnson & Johnson, cutting an estimated $80.8M.
  • PFM Health Sciences fully exited Pfizer in Q3 2022, selling an estimated $70.4M.
  • PFM Health Sciences's ten largest holdings make up 31% of its $2.76B portfolio in Q3 2022.
  • PFM Health Sciences opened 14 new positions and closed 10 in Q3 2022.
  • PFM Health Sciences's portfolio value rose 5.4% quarter-over-quarter to $2.76B.

Based on PFM Health Sciences's 13F filing for Q3 2022, filed 14 Nov 2022.